BridgeMD
Compares treatment options for Diabetes Mellitus
Official title Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring
ClinicalTrials.gov ID: NCT06473480
What this study is testing
- What it's testing
- This clinical trial aims to compare a continuous glucose monitoring system with traditional fingerstick blood glucose monitoring. The study focuses on adult patients in general surgical wards who need regular blood glucose checks due to the risk of low or high blood sugar levels.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 110
You may be able to join if
- Hospitalized patients (≥ 18 years old) in surgical wards
- Glucose measurements at least 4 times (OUH) and 3 times (SUH) daily for at least three days, prescribed by surgeon
- Expected hospitalization for at least three days
- Communicates in Danish
- Signed a declaration of consent to study participation
You likely can't join if
- Cognitively impaired patients
- Indication for glucose monitoring solely because of parenteral nutrition treatment
- Patients admitted with a CGMS
- Patients from the point-of-care fingerstick capillary glucose monitoring group cannot be included in the continuous glucose monitoring system group...
- Nursing staff with at least one month of experience with both point-of-care fingerstick capillary glucose monitoring and continuous glucose...
See the full eligibility criteria
- Hospitalized patients (≥ 18 years old) in surgical wards
- Glucose measurements at least 4 times (OUH) and 3 times (SUH) daily for at least three days, prescribed by surgeon
- Expected hospitalization for at least three days
- Communicates in Danish
- Signed a declaration of consent to study participation
- At risk of hypo- and hyperglycemia (with or without a diabetes diagnosis)
- Specific for substudy 4 as above with the following add on: Patients being treated with insulin at discharge and patients residing within the OUH admission area.
- Cognitively impaired patients
- Indication for glucose monitoring solely because of parenteral nutrition treatment
- Patients admitted with a CGMS
- Patients from the point-of-care fingerstick capillary glucose monitoring group cannot be included in the continuous glucose monitoring system group Eligibility criteria solely for substudy 7 Inclusion Criteria:
- Nursing staff with at least one month of experience with both point-of-care fingerstick capillary glucose monitoring and continuous glucose monitoring system and are registered nurses or certified nursing assistants
The study team makes the final eligibility decision.
Where it's taking place
- Køge, Køge, Denmark
- Odense, Odense, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 110 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Køge, Køge, Denmark; Odense, Odense, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.